Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model.
about
Psoriatic arthritis: pathogenesis and novel immunomodulatory approaches to treatmentAltered bone remodeling in psoriatic arthritisAdalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)Bias in 2-part mixed models for longitudinal semicontinuous data.Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: A systematic and critical review.Predictors of functional deterioration in Chinese patients with psoriatic arthritis: a longitudinal studyLikelihood estimation for a longitudinal negative binomial regression model with missing outcomes.Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitorsIncidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study.Qualifying unmet needs and improving standards of care in psoriatic arthritis.Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis.Rheumatoid and psoriatic knee synovitis: clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept.Psoriatic arthritis: epidemiology, clinical features, course, and outcome.A case-study in the clinical epidemiology of psoriatic arthritis: multistate models and causal arguments.The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland.Predictors for radiological damage in psoriatic arthritis: results from a single centre.Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study.Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective studyPain mechanisms and ultrasonic inflammatory activity as prognostic factors in patients with psoriatic arthritis: protocol for a prospective, exploratory cohort study.Update on the natural history and systemic treatment of psoriasis.Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future.Early detection of spondyloarthropathy in patients with psoriasis by using the ultrasonography and magnetic resonance image.Two-Part and Related Regression Models for Longitudinal Data.Clinical and radiological damage in psoriatic arthritis.Cytokine blockers in psoriatic arthritis.
P2860
Q24813979-A02B9687-DBDF-468E-92AD-5471749D9740Q28288855-50815A38-23E4-4203-A795-E71607518565Q31169591-9EFFC88A-A7A6-4BBE-9FEB-469AFEACEED1Q33399008-3B6C4877-CBB9-4566-88E7-3A2537D04703Q33858767-9E98DE26-10EC-414C-960D-7C6C092CCCDCQ34174214-63393806-CE64-4E66-9B62-FD14B39E1A0EQ34401622-6DDB411C-AACE-44BD-97A6-16060E611135Q34550167-F1B11858-C540-48A6-B53E-7C1BD0AE140DQ34700921-4F41589E-07EC-48E3-B372-74AB5BDE1AB1Q34803582-CE5A34B8-EB86-4B83-BB0E-C27FA107CB13Q35549724-FFA40F73-5345-4205-886B-C7E7BE459095Q35555675-1741D5A5-54E1-4BE5-88BA-5F02B4CAD6FBQ35579437-0616F201-16B8-45F6-8A05-EA7AF3DF553AQ35673043-5ED4125E-6CD1-48BB-B828-999493805831Q35753415-0743883A-F5D7-4E3B-8A2F-BEFAC33FBCCFQ35760034-5754137A-7CC7-4479-8886-E9C6F949FDBEQ35819025-469212FC-0072-40D6-9FA2-990E8FF4D771Q35977689-2D44619E-8624-4A64-ACAC-B64C2FF8E3E2Q36819032-B056722B-853C-4A7E-B753-3CF9A1C5395CQ37081486-ED82B6E6-34A9-4EF9-B390-3319D5793330Q37882064-A28E0918-A5FE-43D4-B763-F78E8D801E31Q41280241-B261CD17-CE9A-4FEF-A4E0-E73A8EAAF6C9Q41502118-D6A7EB7F-595A-4FBC-8CEF-9833F7B6A627Q42174115-D3FA9A26-F822-42A5-9F2E-83DA5A444DD7Q43018087-CE4E737E-A7D8-4353-9ADD-1957AE283102
P2860
Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Clinical indicators of progres ...... tivariate relative risk model.
@en
type
label
Clinical indicators of progres ...... tivariate relative risk model.
@en
prefLabel
Clinical indicators of progres ...... tivariate relative risk model.
@en
P1476
Clinical indicators of progres ...... tivariate relative risk model.
@en
P2093
P304
P407
P577
1995-04-01T00:00:00Z